Correlation Between Ginkgo Bioworks and Apogee Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Ginkgo Bioworks and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ginkgo Bioworks and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ginkgo Bioworks Holdings and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Ginkgo Bioworks and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ginkgo Bioworks with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ginkgo Bioworks and Apogee Therapeutics,.
Diversification Opportunities for Ginkgo Bioworks and Apogee Therapeutics,
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ginkgo and Apogee is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Ginkgo Bioworks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ginkgo Bioworks Holdings are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Ginkgo Bioworks i.e., Ginkgo Bioworks and Apogee Therapeutics, go up and down completely randomly.
Pair Corralation between Ginkgo Bioworks and Apogee Therapeutics,
Considering the 90-day investment horizon Ginkgo Bioworks Holdings is expected to generate 1.39 times more return on investment than Apogee Therapeutics,. However, Ginkgo Bioworks is 1.39 times more volatile than Apogee Therapeutics, Common. It trades about 0.28 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.18 per unit of risk. If you would invest 937.00 in Ginkgo Bioworks Holdings on October 25, 2024 and sell it today you would earn a total of 353.00 from holding Ginkgo Bioworks Holdings or generate 37.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ginkgo Bioworks Holdings vs. Apogee Therapeutics, Common
Performance |
| Timeline |
| Ginkgo Bioworks Holdings |
| Apogee Therapeutics, |
Ginkgo Bioworks and Apogee Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ginkgo Bioworks and Apogee Therapeutics,
The main advantage of trading using opposite Ginkgo Bioworks and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ginkgo Bioworks position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.| Ginkgo Bioworks vs. Ocean Biomedical | Ginkgo Bioworks vs. Enveric Biosciences | Ginkgo Bioworks vs. Hepion Pharmaceuticals | Ginkgo Bioworks vs. Elevation Oncology |
| Apogee Therapeutics, vs. Regeneron Pharmaceuticals | Apogee Therapeutics, vs. The Mosaic | Apogee Therapeutics, vs. Inhibrx | Apogee Therapeutics, vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |